搜索优化
English
网页
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
14 小时
Teva Hits Biden With New Challenge to Medicare Drug Price Talks
Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...
20 小时
Teva call volume above normal and directionally bullish
Bullish option flow detected in Teva (TEVA) with 28,557 calls trading, 1.5x expected, and implied vol increasing almost 16 points to 57.61%.
20 小时
Teva's Delaware Win in Ception Acquistion Dispute Appears Safe
The Delaware Supreme Court appeared skeptical Wednesday of arguments that a trial judge misinterpreted contract language ...
6 小时
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives $20.88 Average Price Target ...
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eight brokerages that are covering the stock, ...
7 天
IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035.
2 天
How Teva Pharmaceuticals is thinking about Trump's return: CEO
Pharmaceutical companies brace for the upcoming Trump administration. Teva Pharmaceuticals (TEVA) CEO Richard Francis joins ...
3 天
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea ...
Klinge Biopharma GmbH (Klinge) holds the exclusive global commercialization rights for FYB203, Formycon's biosimilar ...
3 天
on MSN
Teva inks partnership with Klinge to launch Eylea biosimilar in Europe
Teva Pharmaceutical (NYSE:TEVA) has entered into a strategic collaboration with Klinge Biopharma and Formycon AG, for the ...
3 天
Teva Pharmaceutical’s Growth Potential and Strategic Market Positioning
Analyst Jason Gerberry from Bank of America Securities reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report) and increased ...
FiercePharma
7 天
Catalyst settles with Teva, staving off Firdapse generic until 2035
Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...
news.stocktradersdaily
3 天
(TEVA) Investment Analysis and Advice
Timing Trades in Teva Pharmaceutical Industries Limited American Depositary Shares TEVA can be Risky if you Don't Have ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈